Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.

Neuro-oncology - 1 Mar 2014

Fouse Shaun D, Nakamura Jean L, James C David, Chang Susan, Costello Joseph F

Abstract excerpt

BACKGROUND: Glioblastoma multiforme (GBM) contains a population of cells that exhibit stem cell phenotypes. These cancer stem cells (CSCs) may be a source of therapeutic resistance, although support for this important concept is limited. METHODS: We determined whether early-passage GBM CSCs respo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Antineoplastic Agents, Alkylating
Share to Chemoradiotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dacarbazine

Share to Glioblastoma

Share to Glycoproteins

Share to Neoplastic Stem Cells

Share to Temozolomide

Source

Open in PubMed Open full text

Identifiers

PMID: 24311636
DOI: 10.1093/neuonc/not223
PMCID: PMC3922516

Genes

MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24311636-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.PMID 24311636Read ↗

Chemoresistance of glioblastoma cancer stem cells - much more complex than expectedSemantic proximity Read ↗

Ex vivo stem-like cell families model evolution of glioblastoma therapeutic resistanceSemantic proximity Read ↗

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastomaSemantic proximity Read ↗

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkersSemantic proximity Read ↗

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrenceSemantic proximity Read ↗

Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastomaSemantic proximity Read ↗

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastomaSemantic proximity Read ↗

Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent TumorSemantic proximity Read ↗

The ABCG2 resistance network of glioblastomaSemantic proximity Read ↗

Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.Semantic proximity Read ↗

Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinaseSemantic proximity Read ↗

Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.